Results

Total Results: 1,084 records

Showing results for "phase".

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0215_01-06-2010.pdf
    January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND__0355_09-22-2010.pdf
    January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  3. #05 DEPRESSION (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in phase … Results The table below lists the seven topics for which (1) preliminary phase III data on drugs or … Mifepristone for treating PMD is being investigated in one phase III clinical trial. … Three phase III trials did not individually demonstrate statistical superiority of mifepristone over … Paul, MN) are both in phase III development for DBS for MDD.
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - Results The table below lists the 17 topics for which (1) preliminary phase III data were available … In phase III trials, icatibant provided significant symptom relief within about 2 hours and initial … Placebo- controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. … Placebo- controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. … ThromboGenics' microplasmin phase III program progressing according to schedule. [internet].
  5. effectivehealthcare-admin.ahrq.gov/products/distributed-network-expansion/research
    January 01, 2019 - The enhancements described below will be incorporated into Phase 2 of our Distributed Research Network … We designated this activity as Phase 1.5, to distinguish it from the task order that ended in August … Our approach was based on lessons learned from Phase 1 of DRN and specifically on our findings that a … Data Mart Client Functions Workflow Manager— In this phase, the Data Mart Client was extended so … Document Scope This document describes the functional requirements and design for DRN phase 1.5.
  6. #05 DEPRESSION (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
    October 01, 2014 - Results The table below lists the five topics for which (1) preliminary phase III data for drugs were … Completed phase III trials did not demonstrate statistical superiority of mifepristone over placebo … Paul, MN) are in phase III development for DBS for treating BPD and MDD. … Reclaim/Activa trials for MDD have an anticipated completion date of October 2014; phase III trials … III clinical trial.9 Three completed phase III trials did not demonstrate superiority of mifepristone
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ptsd-comments.pdf
    November 04, 2020 - Since the Phase 1 work and report, we have worked closely with the National Center for PTSD to obtain … Since the Phase 1 work and report, we have worked closely with the National Center for PTSD to obtain … For this phase of development, as recommended by the TEP and NCPTSD, treatments were categorized according … of the PTSD-Repository and updated in this next phase of work. … in a subsequent article highlighting the updates to the PTSD- Repository completed in this second phase
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … None of these topics emerged as eligible for inclusion in this report because preliminary phase III … These topics were ineligible for consideration in this report because no phase III data were available
  9. #05 DEPRESSION (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
    January 01, 2012 - Results The table below lists the 12 topics for which (1) preliminary phase III data on drugs or phase … Mifepristone for treating PMD is being investigated in one phase III clinical trial. … Reclaim is in phase III trials for MDD with an anticipated completion date of October 2014; Libra is … also in phase III trials. … Jude Medical is evaluating its Libra ® DBS system for treatment-resistant depression in the phase
  10. effectivehealthcare-admin.ahrq.gov/products/chronic-urinary-retention/research-protocol
    December 01, 2020 - During the Topic Refinement phase of this project, Key Informants suggested that a review focused on … Key Questions The draft Key Questions (KQs) developed during the Topic Refinement phase were posted … Blind Method/ (118498) Single Blind Method/ (17086) clinical trial/ (476450) clinical trial, phase … i.pt. (12809) clinical trial, phase ii.pt. (20505) clinical trial, phase iii.pt. (7571) clinical … trial, phase iv.pt. (759) controlled clinical trial.pt. (85694) randomized controlled trial.pt.
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
    November 02, 2019 - versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase … Patients With Low- Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase … 26 (763246) 29 27 and 28 (43063) 30 limit 29 to (clinical trial, all or clinical trial, phase … i or clinical trial, phase ii or clinical trial, phase iii or clinical trial, phase iv or clinical
  12. effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies/protocol
    March 01, 2020 - therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase … Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase … 26 (763246) 29     27 and 28 (43063) 30     limit 29 to (clinical trial, all or clinical trial, phase … i or clinical trial, phase ii or clinical trial, phase iii or clinical trial, phase iv or clinical trial
  13. effectivehealthcare-admin.ahrq.gov/products/tethered-spinal-cord/protocol
    August 01, 2023 - Lipomyelomeningocele" OR "tight filum syndrome" Recruitment: Completed studies Study Results: All studies Phase … : Phase 2, Phase 3, Phase 4 ICTRP No limits “tethered cord syndrome” OR “tethered spinal cord” … lying spinal cord” OR “filum terminale syndrome OR Lipomyelomeningocele” OR “tight filum syndrome” Phase … : Phase 2, Phase 3, Phase 4 Cochrane Database of Systematic Reviews tethered cord syndrome OR tethered
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/tethered-spinal-cord-protocol.pdf
    July 19, 2023 - Lipomyelomeningocele" OR "tight filum syndrome" Recruitment: Completed studies Study Results: All studies Phase … : Phase 2, Phase 3, Phase 4 ICTRP No limits “tethered cord syndrome” OR “tethered spinal cord … lying spinal cord” OR “filum terminale syndrome OR Lipomyelomeningocele” OR “tight filum syndrome” Phase … : Phase 2, Phase 3, Phase 4 Cochrane Database of Systematic Reviews tethered cord syndrome OR tethered
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in phase … Results The table below lists three topics in the system for which (1) preliminary phase III or later … Several phase III trials have been cosponsored by the Cystic Fibrosis Foundation, of Bethesda, MD. … In a randomized, double-blind, placebo-controlled, phase III trial, cosponsored by the Cystic Fibrosis … Vertex Pharmaceuticals initiates phase 3 registration program for VX-770, an oral CFTR potentiator
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
    April 01, 2012 - III trials for pharmaceuticals or biotechnologies or in phase II or a trial with some preliminary … The table below lists the three topics for which (1) preliminary phase III were available for drugs … , or phase II, III or later data were available for devices; (2) information was compiled by November … The drug is in several phase III clinical trials cosponsored by the Cystic Fibrosis Foundation. … Vertex Pharmaceuticals initiates phase 3 registration program for VX-770, an oral CFTR potentiator
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_surveillance.pdf
    April 01, 2016 - therapy [CBT or interpersonal therapy [IPT]]) differ in efficacy or effectiveness in treating acute phase … treatments compare with pharmacological treatments in efficacy or effectiveness in treating acute-phase … Current Literature Analysis: • We identified a small phase II RCT examining individuals with MDD who … Tier 3: A small phase II RCT (n=60) examined individuals with MDD who had responded to ECT and … RESULTS: Of 90 MDD patients starting the acute phase, 70% responded and 47% remitted to acute ECT.
  18. SAMHSA (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/goldstrom.pdf
    January 06, 2017 - process and inclusive of many stakeholders, there needs to be sufficient time for feedback at each phase
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0653-131114.pdf
    June 14, 2013 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0263_12-28-2007.pdf
    January 01, 2007 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: